GlassScriptPhysician profile
Burkley Jensen
NPI 1326306630
$4,407.21
in general payments reported to CMS, 2019-2025
24 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $222 · 2021: $1,901 · 2022: $264 · 2023: $390 · 2024: $378 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sioux Surgical INC | $1,270.00 | 2021 | |
| Medical Device Business Services, INC. | $712.73 | 2019 | |
| Arthrex, INC. | $494.00 | 2021 | |
| Smith+Nephew, INC. | $353.93 | 2019-2024 | Pico, Grafix Pl, Stravix |
| Depuy Synthes Sales INC. | $272.93 | 2019-2022 | |
| Stryker Corporation | $214.69 | 2020-2024 | Ortholoc 2 Lapifuse, Augment Injectable, Alphavent |
| Kerecis Limited | $207.36 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $168.53 | 2020-2024 | Puraply, Affinity |
| Mimedx Group, INC. | $160.97 | 2025 | |
| Melinta Therapeutics, LLC | $102.15 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $101.02 | 2020 | |
| Averitas Pharma INC. | $72.56 | 2023-2024 | Qutenza |
| Boston Scientific Corporation | $40.84 | 2024 | |
| Integra Lifesciences Corporation | $36.31 | 2019 | |
| Kci USA, INC. | $30.51 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $28.34 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $27.22 | 2023 | Strensiq |
| Becton, Dickinson and Company | $22.03 | 2024 | Arista Ah Flexitip |
| Bioventus LLC | $18.86 | 2020 | |
| Globus Medical, INC. | $18.45 | 2025 | Senza |
| Allergan, INC. | $16.15 | 2020 | |
| Rsw Medical Company, INC. | $14.21 | 2019 | |
| Abbvie INC. | $12.07 | 2021 | |
| Merck Sharp & Dohme LLC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Burkley Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.